抗生素暴露与食管腺癌风险相关
研究基于美国退伍军人健康管理局2004至2020年数据,采用巢式病例对照设计,纳入8226例食管腺癌病例和140670名匹配对照,评估抗生素暴露与食管腺癌风险的关联。结果显示,任何抗生素暴露与食管腺癌风险升高相关(aOR 1.74,95%CI 1.65-1.83),且风险随累积暴露天数增加而升高(趋势P<.001)。
要点
- 任何抗生素暴露与食管腺癌风险升高相关,aOR为1.74(95%CI 1.65-1.83)。
- 累积暴露1-15天aOR 1.63,16-47天aOR 1.77,≥48天aOR 1.87,趋势P<.001。
- 该发现为假说生成性,提示需探索抗生素暴露在食管腺癌发生或进展中的潜在机制。
核心结论
- 任何抗生素暴露与食管腺癌风险升高相关,且风险随累积暴露天数增加而升高。
- 该新发现为假说生成性,提示需探索可能在食管腺癌发生或进展中起作用的潜在机制。
研究设计与样本
- 采用巢式病例对照研究,数据来自美国退伍军人健康管理局2004年至2020年。
- 病例组为 incident 诊断食管腺癌的患者,每例病例按发病密度抽样匹配最多20名对照。
- 主要暴露为任何口服或静脉抗生素使用;次要暴露包括累积暴露天数和按不同亚组分类的抗生素。
- 采用条件logistic回归估计抗生素暴露与食管腺癌风险的粗比值比和调整比值比(aOR)。
- 分析纳入8226例食管腺癌病例和140670名匹配对照。
主要发现
- 与无抗生素暴露相比,任何抗生素暴露与食管腺癌风险的aOR为1.74(95%CI 1.65-1.83)。
- 与无抗生素暴露相比,累积暴露任何抗生素1至15天的aOR为1.63(95%CI 1.52-1.74;P<.001)。
- 与无抗生素暴露相比,累积暴露16至47天的aOR为1.77(95%CI 1.65-1.89;P<.001)。
- 与无抗生素暴露相比,累积暴露≥48天的aOR为1.87(95%CI 1.75-2.01;P<.001)。
- 累积暴露天数与食管腺癌风险的趋势检验P<.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Antibiotic exposure leads to changes in the gut microbiota. Our objective was to evaluate the association between antibiotic exposure and esophageal adenocarcinoma (EAC) risk. METHODS: We performed a nested case-control study using data from the Veterans Health Administration from 2004 through 2020. The case group consisted of patients who received an incident diagnosis of EAC. For each case, up to 20 matched controls were selected using incidence density sampling. Our primary exposure of interest was any oral or intravenous antibiotic use. Our secondary exposures included cumulative number of days of exposure and classification of antibiotics by various subgroups. Conditional logistic regression was used to estimate the crude and adjusted odds ratios (aORs) for the risk of EAC associated with antibiotic exposure. RESULTS: The case-control analysis included 8226 EAC cases and 140,670 matched controls. Exposure to any antibiotic was associated with an aOR for EAC of 1.74 (95% confidence interval [CI], 1.65-1.83) vs no antibiotic exposure. Compared with no antibiotic exposure, the aOR for EAC was 1.63 (95% CI, 1.52-1.74; P < .001) for cumulative exposure to any antibiotic for 1 to 15 days; 1.77 (95% CI, 1.65-1.89; P < 0 .001) for 16 to 47 days; and 1.87 (95% CI, 1.75-2.01; P < .001) for ≥48 days, respectively (P for trend < .001). CONCLUSION: Exposure to any antibiotic is associated with an increased risk of EAC, and this risk increases as the cumulative days of exposure increase. This novel finding is hypothesis-generating for potential mechanisms that may play a role in the development or progression of EAC.
引用
- Thanawala SU, Kaplan DE, Falk GW, et al. Antibiotic Exposure is Associated With a Risk of Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2023. PMID: 36967101. doi:10.1016/j.cgh.2023.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。